Welcome to the Cardiogenics Holdings Discussion Forum

Paramagnetic Beads and QL Analyser are Proprietary Products

Free
Message: Recent presentation material

Game,

Two different studies but one protocol; which is why Cardiogenics will be able to initiate the second study so quickly. So if the Beta Site study produces a significant p value, the risk of success in the second study will be minimized to Cardiogenics and its shareholders.

Ante

Share
New Message
Please login to post a reply